SEONGNAM, South Korea, Feb. 6, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO: Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the initiation of a Phase 1 clinical trial in...
Hence then, the article about pharmaresearch receives u s fda clearance to initiate phase 1 clinical trial of nano anticancer drug prd 101 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101 )
Also on site :
- Police: Two killed in shooting at West San Jose shopping center
- Judge Rules That ICE Agents Violate the Fourth Amendment by Making Arrests While Masked
- Google’s new 1.9GW clean energy deal includes massive 100-hour battery